Two-Year Outcomes of Treatment-Experienced Adults After Programmatic Transitioning to Dolutegravir: Longitudinal Data From the VICONEL Human Immunodeficiency Virus Cohort in Lesotho

In the Viral Load Cohort North-East Lesotho (VICONEL) human immunodeficiency virus cohort, 14 242 adults had transitioned from efavirenz- or nevirapine-based antiretroviral therapy (ART) to dolutegravir-based ART by October 2021. Rates of viral suppression to <50 copies/mL were 84.8%, 93.9%, and...

Descripción completa

Detalles Bibliográficos
Autores principales: Tschumi, Nadine, Lerotholi, Malebanye, Motaboli, Lipontso, Mokete, Moliehi, Labhardt, Niklaus D, Brown, Jennifer A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10640687/
https://www.ncbi.nlm.nih.gov/pubmed/37358226
http://dx.doi.org/10.1093/cid/ciad390

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10640687/
https://www.ncbi.nlm.nih.gov/pubmed/37358226
http://dx.doi.org/10.1093/cid/ciad390

Ejemplares similares